Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
Cyclosporine Plus Methotrexate or Alemtuzumab
A Phase I Extension Trial of Repeated Infusions of ISF35
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
† Study has passed its completion date and status has not been verified in more than two years.